B
IDXX icon

Birchbrook’s Idexx Laboratories IDXX Stock Holding History

Birchbrook’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Sell
4,477
-37
-0.8% -$20.8K 1.11% 18
2026
Q1 		$2.54M Sell
4,514
-115
-2% -$73.7K 1.24% 18
2025
Q4 		$3.13M Sell
4,629
-89
-2% -$60.6K 1.56% 15
2025
Q3 		$3.01M Sell
4,718
-30
-0.6% -$18.2K 1.56% 13
2025
Q2 		$2.55M Sell
4,748
-1,145
-19% -$548K 1.36% 15
2025
Q1 		$2.47M Buy
5,893
+48
+0.8% +$20.8K 1.39% 14
2024
Q4 		$2.42M Buy
5,845
+88
+2% +$38.6K 1.37% 16
2024
Q3 		$2.91M Buy
5,757
+214
+4% +$104K 1.61% 12
2024
Q2 		$2.7M Sell
5,543
-37
-0.7% -$18.6K 1.62% 12
2024
Q1 		$3.01M Sell
5,580
-284
-5% -$155K 1.79% 10
2023
Q4 		$3.25M Buy
+5,864
New +$2.75M 2.15% 9

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Birchbrook's IDXX Position: Q2 2026 in Review

Birchbrook reduced its Idexx Laboratories (IDXX) stake by 0.82% in Q2 2026, selling an estimated $20.8K and leaving 4,477 shares worth $2.36M. The position accounts for 1.11% of the portfolio, ranked #18.

Birchbrook first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.25M in Q4 2023. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Birchbrook held 4,477 shares of Idexx Laboratories worth $2.36M as of Q2 2026.
  • Birchbrook sold 37 Idexx Laboratories shares in Q2 2026, an estimated $20.8K.
  • Idexx Laboratories made up 1.11% of Birchbrook's portfolio in Q2 2026, its #18 holding.
  • Birchbrook first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's Idexx Laboratories position peaked at $3.25M in Q4 2023.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.